ECILC vs ULKER Comparison
Price, market cap, valuation, profitability and leverage metrics of ECILC and ULKER side by side.
If You Had Invested TRY 10,000
Metric Comparison
| Metric | ECILC | ULKER | Sector median |
|---|---|---|---|
| Last price (TL) | 64.00 | 85.45 | 18.72 |
| Daily change | −6.57% | −3.01% | −5.35% |
| Market cap | TRY 43.9B | TRY 31.6B | TRY 4.4B |
| P/E | — | 7.24 | 17.25 |
| P/B | 0.68 | 0.64 | 1.08 |
| Dividend yield | 2.04% | 5.17% | 0.90% |
| Return on equity | −3.08% | 9.85% | 1.78% |
| Free float | 22.02% | 44.47% | 37.21% |
Popular Comparisons
Related Pages
About the ECILC vs ULKER Comparison
Price, market cap, valuation multiples, profitability and leverage of ECILC (Eczacıbaşı İlaç) and ULKER (Ülker Bisküvi) side by side as of Sep 28, 2026, 16:43. Of the 16 metrics compared, ECILC leads in 5 and ULKER leads in 11.
Highlights: Daily change: ULKER leads (−3.01% vs −6.57%). Market cap: ECILC leads (TRY 43.9B vs TRY 31.6B). P/B: ULKER leads (0.64 vs 0.68). EV/EBITDA: ULKER leads (5.12 vs 165.19). EV/Sales: ULKER leads (1.18 vs 9.35). Dividend yield: ULKER leads (5.17% vs 2.04%). Gross margin: ECILC leads (37.83% vs 26.46%). EBITDA margin (annual): ULKER leads (18.03% vs 11.49%).
Frequently Asked Questions
Is ECILC or ULKER cheaper?
By P/E, Tie is cheaper (— vs 7.24); by P/B, ULKER trades at the lower multiple (0.68 vs 0.64).
Which is more profitable, ECILC or ULKER?
Annual net margin is −20.86% for ECILC and 4.20% for ULKER; return on equity is −3.08% for ECILC and 9.85% for ULKER.
Which is more leveraged, ECILC or ULKER?
The leverage ratio is 18.92 for ECILC and 62.67 for ULKER; net debt/EBITDA is 1.37 for ECILC and 2.18 for ULKER. Lower values mean less leverage.
Where does the comparison data come from?
Prices and market caps come from 15-minute delayed Borsa Istanbul data; ratios are calculated from the latest financial statements filed with KAP. Some ratios are not defined for banks and insurers.